| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/07/2007 | CA2182388C Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
| 08/07/2007 | CA2092718C Use of protective agents against reactive oxygen species |
| 08/07/2007 | CA2071863C Recombinant vaccine for porcine pleuropneumonia |
| 08/02/2007 | WO2007086587A1 Agent for targeting drug to cerebral neuron |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086554A1 Tropane compound and pharmaceutical composition containing the same as active ingredient |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086504A1 Carboxylic acid compound and use thereof |
| 08/02/2007 | WO2007086471A1 Process for production of lasofoxifene or analogue thereof |
| 08/02/2007 | WO2007069925A3 Non-neurotoxic recreational drugs and a method of treating recreational drug abuse |
| 08/02/2007 | WO2007047724A3 Compositions for lowering serum cholesterol and/or triglycerides |
| 08/02/2007 | WO2007047722A3 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 08/02/2007 | WO2007035121A3 Isoflavones for treating mucopolysaccharidoses |
| 08/02/2007 | WO2006112549A8 Fused heterocyclic compound |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179154 Coumarin derivatives, process for their production and use thereof |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178177 Beverage and medicament containing bamboo extract as a main ingredient |
| 08/02/2007 | US20070178175 Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same |
| 08/02/2007 | US20070178083 Medicinal compositions containing Fc receptor gamma-chain activator |
| 08/02/2007 | US20070178079 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci |
| 08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | DE102006003996A1 Method for the formation of heart muscle cells (cardiomyocytes), useful e.g. in medical application, comprises culturing and differentiating stem cells, which are obtained from differentiated exocrine gland tissue of an organism |
| 08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 08/01/2007 | EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 08/01/2007 | EP1813620A1 Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates |
| 08/01/2007 | EP1813613A1 Novel fused imidazole derivative |
| 08/01/2007 | EP1813603A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 08/01/2007 | EP1813602A1 Crystal of two-ring heterocyclic sulfonamide compound |
| 08/01/2007 | EP1813309A1 Abnormal protein removing composition |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1813279A1 Concentrated hemodialysis solutions |
| 08/01/2007 | EP1813270A1 Hsp90 family protein inhibitors |
| 08/01/2007 | EP1813250A1 External preparation |
| 08/01/2007 | EP1812021A2 Once a day formulation for phosphate binders |
| 08/01/2007 | EP1812018A1 Treatment and prevention of multi-drug resistance |
| 08/01/2007 | EP1811996A1 Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
| 08/01/2007 | EP1811839A2 Methods and compositions related to esculentoside a |
| 08/01/2007 | EP1537124B1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 08/01/2007 | EP1377542B1 Hiv protease inhibitors based on amino acid derivatives |
| 08/01/2007 | EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 08/01/2007 | EP1313715B1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
| 08/01/2007 | EP1294714B1 Thrombin receptor antagonists |
| 08/01/2007 | EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents |
| 08/01/2007 | EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1242098B1 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | CN1329396C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | CN1329395C Tricyclic imidazopyridines |
| 08/01/2007 | CN1329394C Novel imidazole derivatives, production method thereof and use thereof |
| 08/01/2007 | CN1329392C Substituted pyrazoles |
| 08/01/2007 | CN1329389C Novel compounds and their use |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 08/01/2007 | CN1329375C Novel anti-diabetic agents |
| 08/01/2007 | CN1329359C Ether compounds, compositions, and uses thereof |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329036C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 08/01/2007 | CN101010337A Fas associated factor 1 |
| 08/01/2007 | CN101010304A Molecular chaperone function regulator |
| 08/01/2007 | CN101010079A Remedy for glomerular diseae |
| 08/01/2007 | CN101007815A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007790A Oxamic acid derivative, and its preparation method and medicinal uses |
| 08/01/2007 | CN101007172A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 08/01/2007 | CN101007090A Health-preserving and growth-promoting Chinese medicinal additive for pig |
| 08/01/2007 | CN101006863A A granular health product of panax natoginseng |
| 08/01/2007 | CN101006846A Anti-stress nutrition additives for poultry and its preparation method |
| 08/01/2007 | CN101006831A Premixed compound fodder for fattening pig containing trace elements and vitamins |
| 08/01/2007 | CN101006827A Combination formula of green feed additive and its processing method and application |
| 08/01/2007 | CN101006817A Bamboo leaf tea and its producing method |
| 07/31/2007 | US7250522 Reacting a 5-thio-D-aldohexopyranose derivative with a hydroxyaromatic compound in the presence of a phosphine and an azo reagent; Mitsunobu reaction conditions; useful as an sodium-dependent glucose transporter (SGLT2) inhibitor; beta-selective glycosylation |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250429 Aminomethyl-substituted thiazolobenzimidazole compounds |
| 07/31/2007 | US7250424 Fab I inhibitors |
| 07/31/2007 | US7250411 Benzothiazine and benzothiadiazine compounds |
| 07/31/2007 | US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 07/31/2007 | US7250409 Ningalin B analogs employable for reversing multidrug resistance |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |